Q2 2022 Oncopeptides AB Earnings Call Transcript
Good day, and welcome to the Oncopeptides Q2 2022 Earnings Conference Call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Jakob Lindberg, CEO of Oncopeptides. Please go ahead, sir.
()-
Thank you very much, and a warm welcome, everyone, to this quarter 2 webcast of Oncopeptides AB.
Let's go straight to the disclaimer slide, Slide #2. As always, we're going to make future-looking statements, et cetera, and for anyone interested in the legal sort of reads of this, read -- just read the disclaimer. It's available on our webpage, and it's just the usual disclaimers, of course.
Going to Slide #3. With me today, I also have Dr. Klaas Bakker, Chief Medical Officer; and Annika Muskantor, Chief Financial Officer. And we will all be available for questions and answers at the end of this session, obviously.
Going straight to Slide #4, we're going to give a brief update of the quarter as such. And
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
